Details for New Drug Application (NDA): 074025
✉ Email this page to a colleague
NDA 074025 describes GUANABENZ ACETATE, which is a drug marketed by Ani Pharms, Chartwell Rx, and Watson Labs, and is included in four NDAs. Additional details are available on the GUANABENZ ACETATE profile page.
The generic ingredient in GUANABENZ ACETATE is guanabenz acetate. There are six drug master file entries for this compound. Additional details are available on the guanabenz acetate profile page.
The generic ingredient in GUANABENZ ACETATE is guanabenz acetate. There are six drug master file entries for this compound. Additional details are available on the guanabenz acetate profile page.
Summary for 074025
| Tradename: | GUANABENZ ACETATE |
| Applicant: | Watson Labs |
| Ingredient: | guanabenz acetate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 074025
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 4MG BASE | ||||
| Approval Date: | Feb 28, 1994 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 8MG BASE | ||||
| Approval Date: | Feb 28, 1994 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
